Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Meijer, J. H.
Dekker, N.
Koeter, M. W.
Quee, P. J.
van Beveren, N. J. M.
and
Meijer, C. J.
2012.
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Psychological Medicine,
Vol. 42,
Issue. 4,
p.
705.
Schnell, Thomas
Kleiman, Alexandra
Gouzoulis-Mayfrank, Euphrosyne
Daumann, Jörg
and
Becker, Benjamin
2012.
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel-based morphometric study using DARTEL.
Schizophrenia Research,
Vol. 138,
Issue. 2-3,
p.
183.
Potvin, Stéphane
Stavro, Katherine
and
Pelletier, Julie
2012.
Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors.
Journal of Dual Diagnosis,
Vol. 8,
Issue. 1,
p.
35.
Donoghue, K.
Mazzoncini, R.
Hart, J.
Zanelli, J.
Morgan, C.
Dazzan, P.
Morgan, K. D.
Murray, R. M.
Jones, P. B.
and
Doody, G. A.
2012.
The differential effect of illicit drug use on cognitive function in first‐episode psychosis and healthy controls.
Acta Psychiatrica Scandinavica,
Vol. 125,
Issue. 5,
p.
400.
Avdesh, Avdesh
Hoe, Yikai
Martins, Ralph N.
and
Martin-Iverson, Mathew T.
2013.
Pharmacological effects of cannabinoids on the reference and working memory functions in mice.
Psychopharmacology,
Vol. 225,
Issue. 2,
p.
483.
Benaiges, Irina
Serra-Grabulosa, Josep Maria
and
Adan, Ana
2013.
Neuropsychological functioning and age-related changes in schizophrenia and/or cocaine dependence.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 40,
Issue. ,
p.
298.
Crane, Natania A.
Schuster, Randi Melissa
Fusar-Poli, Paolo
and
Gonzalez, Raul
2013.
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences.
Neuropsychology Review,
Vol. 23,
Issue. 2,
p.
117.
Thoma, Patrizia
and
Daum, Irene
2013.
Comorbid substance use disorder in schizophrenia: A selective overview of neurobiological and cognitive underpinnings.
Psychiatry and Clinical Neurosciences,
Vol. 67,
Issue. 6,
p.
367.
Cao, Xiao‐yan
Li, Zhi
Metcalfe, Hugo M.
Yang, Tian‐xiao
Tan, Shu‐ping
Wang, Ya
Hong, Xiao‐hong
Li, Zhan‐jiang
Yu, Xin
Cheung, Eric F. C.
Neumann, David L.
Shum, David H. K.
and
Chan, Raymond C. K.
2013.
The nature and extent of working memory dysfunction in schizophrenia.
PsyCh Journal,
Vol. 2,
Issue. 3,
p.
175.
Benaiges, Irina
Serra‐Grabulosa, Josep Maria
Prat, Gemma
and
Adan, Ana
2013.
Executive functioning in individuals with schizophrenia and/or cocaine dependence.
Human Psychopharmacology: Clinical and Experimental,
Vol. 28,
Issue. 1,
p.
29.
Schaefer, Jonathan
Giangrande, Evan
Weinberger, Daniel R.
and
Dickinson, Dwight
2013.
The global cognitive impairment in schizophrenia: Consistent over decades and around the world.
Schizophrenia Research,
Vol. 150,
Issue. 1,
p.
42.
Radhakrishnan, Rajiv
Addy, Peter H.
Sewell, R. Andrew
Skosnik, Patrick D.
Ranganathan, Mohini
and
D’Souza, Deepak Cyril
2014.
The Effects of Drug Abuse on the Human Nervous System.
p.
423.
Bahorik, Amber L.
Cornelius, Jack R.
Bangalore, Srihari S.
Newhill, Christina E.
Keshavan, Matcheri S.
and
Eack, Shaun M.
2014.
Brief report: The impact of alcohol and cannabis misuse on cognition among individuals with schizophrenia.
Schizophrenia Research: Cognition,
Vol. 1,
Issue. 3,
p.
160.
Yong, Emma
Barbato, Mariapaola
Penn, David L.
Keefe, Richard S.E.
Woods, Scott W.
Perkins, Diana O.
and
Addington, Jean
2014.
Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis.
Psychiatry Research,
Vol. 218,
Issue. 1-2,
p.
39.
Price, Jenessa S.
McQueeny, Tim
Shollenbarger, Skyler
Browning, Erin L.
Wieser, Jon
and
Lisdahl, Krista M.
2015.
Effects of marijuana use on prefrontal and parietal volumes and cognition in emerging adults.
Psychopharmacology,
Vol. 232,
Issue. 16,
p.
2939.
Power, Brian D.
Dragovic, Milan
Badcock, Johanna C.
Morgan, Vera A.
Castle, David
Jablensky, Assen
and
Stefanis, Nikos C.
2015.
No additive effect of cannabis on cognition in schizophrenia.
Schizophrenia Research,
Vol. 168,
Issue. 1-2,
p.
245.
Broyd, Samantha J.
van Hell, Hendrika H.
Beale, Camilla
Yücel, Murat
and
Solowij, Nadia
2016.
Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review.
Biological Psychiatry,
Vol. 79,
Issue. 7,
p.
557.
Bloomfield, M. A. P.
Mouchlianitis, E.
Morgan, C. J. A.
Freeman, T. P.
Curran, H. V.
Roiser, J. P.
and
Howes, O. D.
2016.
Salience attribution and its relationship to cannabis-induced psychotic symptoms.
Psychological Medicine,
Vol. 46,
Issue. 16,
p.
3383.
Waterreus, Anna
Badcock, Johanna C.
Di Prinzio, Patsy
Martin-Iverson, Mathew
and
Morgan, Vera A.
2017.
The impact of current cannabis use on general cognitive function in people with psychotic illness.
Schizophrenia Research,
Vol. 190,
Issue. ,
p.
164.
Harvey, Philip D.
and
Rosenthal, Jennifer B.
2018.
Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?.
Schizophrenia Research,
Vol. 196,
Issue. ,
p.
14.